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Abstract
Heart failure is a worldwide leading cause of death. Diet and obesity are particularly of high concern in heart disease
etiology. Gravely, altered nutrition during developmental windows of vulnerability can have long-term impact on
heart health; however, the underlying mechanisms are poorly understood. In the understanding of the initiation of
chronic diseases related to developmental exposure to environmental challenges, deregulations in epigenetic
mechanisms including micro-RNAs have been proposed as key events. In this context, we aimed at delineating the
role of micro-RNAs in the programming of cardiac alterations induced by early developmental exposure to nutritional
imbalance. To reach our aim, we developed a human relevant model of developmental exposure to nutritional
imbalance by maternally exposing rat to high-fat diet during gestation and lactation. In this model, offspring exposed
to maternal high-fat diet developed cardiac hypertrophy and increased extracellular matrix depot compared to those
exposed to chow diet. Microarray approach performed on cardiac tissue allowed the identification of a micro-RNA
subset which was down-regulated in high-fat diet-exposed animals and which were predicted to regulate
transforming growth factor-beta (TGFβ)-mediated remodeling. As indicated by in vitro approaches and gene
expression measurement in the heart of our animals, decrease in DiGeorge critical region 8 (DGCR8) expression,
involved in micro-RNA biogenesis, seems to be a critical point in the alterations of the micro-RNA profile and the
TGFβ-mediated remodeling induced by maternal exposure to high-fat diet. Finally, increasing DGCR8 activity and/or
expression through hemin treatment in vitro revealed its potential in the rescue of the pro-fibrotic phenotype in
cardiomyocytes driven by DGCR8 decrease. These findings suggest that cardiac alterations induced by maternal
exposure to high-fat diet is related to abnormalities in TGFβ pathway and associated with down-regulated micro-RNA
processing. Our study highlighted DGCR8 as a potential therapeutic target for heart diseases related to early exposure
to dietary challenge.
Introduction
A worldwide upward trend in the burden of non-
communicable diseases such as cancers, stroke, heart and
chronic lung diseases is currently observed. These dis-
eases share common risks factors that are related to life-
style including smoking, physical inactivity, alcohol and
unhealthy diet consumption (World Health Organization
(WHO); https://www.who.int/ncds/en/). Importantly,
these factors have even more serious impact on health
when the exposure occurs during developmental windows
of vulnerability such as in utero and early post-natal life.
As such, maternal overweight and obesity, the incidence
of which are increasing (WHO; http://www.who.int/en/
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and which are often attributed to excessive intake of
calorie-dense food, in particular high-fat diets, and
reduced physical activity1, not only have consequences in
the short term with pregnancy complications, but also
impact offspring health later during life. Maternal obesity
and dietary imbalances are particularly of high concern in
the early origins of heart failure2,3. Since human cardio-
myocyte have limited proliferative capacity, the exposure
of the developing heart to environmental challenges such
as nutritional excess may have deleterious effects on
lifelong cardiomyocyte functions4. Indeed, maternal
exposure to high-fat diet and maternal obesity increases
the risk for impaired cardiac function in adulthood by
modifying heart rate and inducing left ventricular wall
thickness, hypertrophy5 and fibrosis6,7. In the early origins
of heart diseases, epigenetic mechanisms are likely key
players. In particular, micro-RNAs, which belong to small
non-coding RNAs (around 22 nucleotides in length)
involved in each step of heart development, seem to play a
crucial role in the unfavorable programming of heart
diseases8. By controlling about 60% of all protein-coding
genes in mammals, micro-RNAs are considered as sig-
nificant post-transcriptional regulators of gene expres-
sion9, and regulate almost all biological processes
including development, differentiation, proliferation,
apoptosis, metabolism and tissue remodeling. The critical
role of maintaining micro-RNA balance in the heart has
been revealed notably in models of mice where cardio-
myopathies were induced by inhibiting the expression of
proteins involved in micro-RNA biogenesis in cardio-
myocytes10–12. Micro-RNA biogenesis is a regulated
multistep process starting in the cell nucleus where pri-
mary micro-RNAs (pri-micro-RNAs) are transcribed
mainly by RNA polymerase II. Through the action of a
microprocessor complex including nuclear ribonuclease
III (DROSHA) and its cofactor DiGeorge critical region 8
(DGCR8), pri-micro-RNAs are trimmed into 70 nucleo-
tide hairpins called precursor micro-RNAs (pre-micro-
RNAs)13. Then, pre-micro-RNAs assembles into a
complex constituted by Exportin-5 (XPO5) and RanGTP
and translocate into the cytoplasm14 where they continue
their maturation, through a splicing realized by a complex
including DICER and TAR RNA-binding protein 2
(TRBP). This results in RNA duplexes comprising the
mature micro-RNAs and the passenger strand, micro-
RNAs*15. Finally, each mature single strand micro-RNA
strand is incorporated into the RNA-induced silencing
complex (RISC) comprising an Argonaute (AGO) protein
to direct the silencing of the targeted mRNA16. Interest-
ingly, the micro-RNA biogenesis machinery is sensitive to
hormonal regulation and dietary changes17–19. In this
context, micro-RNAs and their regulation represent a
potential candidate in the understanding of the long-term
effects on cardiac functions induced by exposure to
nutritional challenges early during development. Thus,
based on a human relevant model of cardiac alterations
programmed by exposure to maternal high-fat diet, we
aimed at delineating the role of micro-RNAs, identifying
the defects in the micro-RNA biogenesis machinery in
such programming and at highlighting potential targets
and approaches for the phenotype reversal.
Results
Exposure to maternal high-fat diet induces cardiac
hypertrophy and increases cardiac extracellular matrix
depot
At post-natal day 77 (PND77), whereas no difference
was detected in the body weight of animals exposed to
chow diet (CTRL) or to high-fat diet (HFD) (supple-
mentary data S1), increased heart vs. body weight ratio
was induced by maternal exposure to high-fat diet
(Fig. 1a). This was associated with enlarged cardiomyo-
cytes visualized by hematoxylin–eosin staining (Fig. 1b).
In addition, exposure to high-fat diet increased extra-
cellular matrix depot as indicated by Masson’s trichrome
staining (Fig. 1c). These data indicate that maternal
exposure to high-fat diet induced cardiac remodeling with
hypertrophic and fibrotic patterns, without changes in the
body weight at PND77.
Exposure to maternal high-fat diet alters adult cardiac
micro-RNA levels
Since micro-RNAs have been described as effectors of
environmental influences on gene expression and dis-
ease20, and because alterations in micro-RNA balance
have been reported to induce cardiac hypertrophy and
fibrosis, we wondered what could be the role of micro-
RNAs in the cardiac tissular alterations induced by
maternal exposure to high-fat diet. With such an aim, we
analyzed the micro-RNA profile by microarray experi-
ment. The microarray quality control data are presented
in supplemental data S2. The comparison of micro-RNA
profile between rats exposed to chow diet (CTRL) or to
HFD highlighted 19 down-regulated micro-RNAs, with
an adjusted P value < 0.05 (Fig. 2a). Nine micro-RNAs
(let-7g, miR-15, miR-21, miR-27a, miR-29c, miR-33,
miR-101a, miR-218a and miR-450a) were selected for
quantitative real-time PCR (RT-qPCR) validation of the
microarray data (Fig. 2b). Except for miR-15 where no
modification was detected, RT-qPCR data correlated well
with those obtained from the microarray for all selected
micro-RNAs, confirming the down-regulation of micro-
RNA levels in the heart of animals exposed to maternal
high-fat diet compared to the ones exposed to chow
diet. All the 19 significantly differentially expressed
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micro-RNAs have previously been reported in experi-
mental or human cardiovascular diseases (supplemental
table 2). The targets of the altered micro-RNAs have been
reported to play a role in metabolism, cardiogenesis, cell
survival, hypertrophy and fibrosis (Fig. 3). Collectively,
these data suggest that tissular cardiac alterations
observed in the heart of animals exposed to maternal
high-fat diet are linked to the down-regulation of a micro-
RNA subset regulating cellular mechanisms that are cri-
tical for cardiac functions.
Fig. 1 Effects of maternal exposure to high-fat diet on adult heart. (a) Heart vs. body weight ratio of animals exposed to chow diet (CTRL) or
high-fat diet (HFD). Data are expressed as mean ± SEM; n= 18 per group. Representative heart section image from a male rat at post-natal day 77
under control chow diet (CTRL) or HFD stained with hematoxylin–eosin staining for cell morphology analyses (scale bar= 50 μm) (b) and Masson’s
trichrome to evaluate extracellular matrix depot (scale bar= 100 μm) (c). *P < 0.05 and **P < 0.01 compared to control
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Altered cardiac micro-RNAs are involved in cardiac
diseases and associated pathways
To identify regulatory networks involved in the adult
heart dysfunctions induced by maternal exposure to high-
fat diet, we performed a computational target prediction
analysis coupled to pathway analysis using DIANA-
miRPath (v3.0) software. Notably, KEGG (Kyoto Ency-
clopedia of Genes and Genomes) pathway analysis
showed that the altered micro-RNAs are predicted to
target extracellular matrix–receptor interaction, fatty acid
degradation and metabolism. The DIANA-miRPath soft-
ware calculates the significance for all the miRNA–mRNA
pairs in a pathway, and then combines them into a
merged P value for each pathway21. The results are
reported as heat maps, and the pathways are clustered
based on significance levels (Fig. 4a). A closer look at the
altered micro-RNA targets revealed that the majority of
the altered micro-RNAs are involved in transforming
growth factor-beta (TGFβ) signaling which is closely
linked to extracellular matrix–receptor interaction and
involved in cardiac fibrosis and hypertrophy (Fig. 4b). In
the response to cardiac stress, TGFβ is subsequently
activated and triggers a cascade of signaling involving
SMAD protein phosphorylation (canonical pathway) or
the activation of other intermediates such as mechanistic
target of rapamycin (mTOR) or mitogen-activated protein
Fig. 2 Effects of maternal exposure to high-fat diet on adult cardiac micro-RNA levels. (a) Differential expression of micro-RNAs detected by
microarray in the heart of male rats at post-natal day 77 exposed to maternal high-fat diet compared to chow diet. (b) let-7g, miR-15, miR-21,
miR-27a, miR-29c, miR-33, miR-101a, miR-218a and miR-450a levels were analyzed by quantitative real-time PCR (RT-qPCR) in the heart of male rats at
post-natal day 77 under control chow diet (CTRL) or high-fat diet (HFD). Data are expressed as mean ± SEM; n= 13 per group. *P < 0.05, ***P < 0.001
and ****P < 0.0001 compared to control, ns not statistically significant
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kinase (MAPK) (non-canonical pathway), leading to the
up-regulation of the expression of genes involved notably
in the regulation of extracellular matrix synthesis and cell
growth (Fig. 4b). As such, the dysregulation of TGFβ
pathway has been shown to result in fibrosis and hyper-
trophy22. In light of these points, we supposed that the
cardiac hypertrophy and fibrosis induced by maternal
exposure to high-fat diet are due to micro-RNA-mediated
TGFβ pathway dysregulation.
Exposure to maternal high-fat diet alters the expression of
genes involved in TGFβ regulated hypertrophy and fibrosis
To verify whether the micro-RNA down-regulation was
associated with alterations in the TGFβ pathway in the
heart of animals exposed to maternal high-fat diet, we
measured the expression levels of the predicted targets of
these micro-RNAs, involved in TGFβ-mediated fibrosis
and hypertrophy. Effectively, in the heart of animals
exposed to high-fat diet compared to chow diet, increased
transforming growth factor-beta receptor type III
(TGFβR3) mRNA levels were detected (Fig. 5a). This was
associated with increased expression of pro-hypertrophic
genes such as V-Ki-ras2 Kirsten rat sarcoma viral
oncogene homolog (K-RAS), protein kinase C epsilon
(PRKCE), increased phosphorylation of ribosomal protein
s6 kinase (RPS6KB1, a target of mTOR), and increased
expression of pro-fibrotic genes such as connective tissue
growth factor (CTGF) and secreted protein acidic
cysteine-rich (SPARC) (Fig. 5b). These data suggest that
cardiac hypertrophy and fibrosis induced by maternal
exposure to high-fat diet might be due to micro-RNA-
mediated TGFβ pathway dysregulation at multiple levels.
Maternal exposure to high-fat diet modifies the expression
of proteins involved in micro-RNA processing
Prompting a search for underlying mechanisms in
micro-RNA down-regulation induced by maternal expo-
sure to high-fat diet, we investigated the different steps of
micro-RNA biogenesis by measuring the expression levels
of key components of the micro-RNA biogenesis
machinery: DROSHA, DGCR8, DICER, XPO5 and AGO2
(Fig. 6a). Among them, DGCR8 showed a significant
decrease at the protein (Fig. 6a) and mRNA (Fig. 6b) levels
when the animals were exposed to maternal high-fat diet.
These data suggest that DGCR8-decreased expression
may be responsible for micro-RNA down-regulation
Fig. 3 Role of the down-regulated micro-RNAs in heart disease. Scheme representing the putative targets of the micro-RNAs down-regulated by
maternal exposure to high-fat diet, reported in heart diseases related to the regulation of metabolism, cardiogenesis, cell survival, hypertrophy and
fibrosis
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induced by maternal exposure to high-fat diet, and the
subsequent cardiac alterations mediated by TGFβ path-
way dysregulations.
DGCR8 down-regulation effects on micro-RNA levels and
TGFβ pathway
To delineate the role of DGCR8 in the regulation of
micro-RNA levels in cardiomyocytes, we down-regulated
its expression in H9C2 cell line. In these cells, the trans-
fection of a specific gapmeR targeting Dgcr8 (gap DGCR8)
induced a 74% decrease in Dgcr8 mRNA levels compared
to the cells transfected with a control gapmeR (negative
control, gap CTRL) (Fig. 7a). Difference in cell survival
was not detected when Dgcr8 was inhibited (supplemental
data). In contrast, the levels in let-7g, miR-21, miR-27a,
miR-29c, miR-33, miR-101a and miR-218a were
Fig. 4 Effects of maternal exposure to high-fat diet on the expression of genes involved in transforming growth factor-beta (TGFβ)-
regulated hypertrophy and fibrosis. (a) Cluster heat maps showing the pathways which are predicted to be altered based on significance levels.
The more intense red color indicates higher probability that a specific pathway is significantly enriched with target genes for a certain micro-RNA.
(b) Scheme representing the involvement of down-regulated micro-RNAs in the regulation of canonical and non-canonical TGFβ pathways. Putative
inhibition of genes by micro-RNAs is represented by green line. Dotted lines represent direct or indirect stimulation of the pathway
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down-regulated in these cells (Fig. 7b). We then verified
the role of Dgcr8 and micro-RNA decrease on the reg-
ulation of genes involved in TGFβ-mediated fibrosis and
hypertrophy pathway (Fig. 7b, c). We found that Dgcr8
down-regulation through gapmeR transfection induced a
significant increase in Tgfβr3 (Fig. 7b). The mRNA levels
Fig. 5 Effects of maternal exposure to high-fat diet on the expression of genes involved in transforming growth factor-beta (TGFβ)-
regulated hypertrophy and fibrosis. (a) mRNA and (b) protein levels of putative target genes involved in TGFβ-mediated remodeling were
analyzed in the heart from male rats at post-natal day 77 under control chow diet (CTRL) or high-fat diet (HFD). In (b), a representative immunoblot
image is presented for each protein. Data are expressed as the mean ± SEM; n= 13 per group. *P < 0.05, and ***P < 0.001 compared to control, ns not
statistically significant
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of pro-hypertrophic genes such as K-Ras, mTor, Hdac8,
Prkce and Ccnd2 were upregulated when Dgcr8 expres-
sion was decreased (Fig. 7c). Similarly, pro-fibrotic genes
such as Ctgf, Sparc, Col3a1 and FasL showed increased
mRNA levels in cells where Dgcr8 expression was inhib-
ited (Fig. 7d). These data indicate that Dgcr8 decrease
in vitro can induce the down-regulation of a subset of
micro-RNAs involved in TGFβ pathway regulation,
through the regulation of multiple targets involved in the
canonical and non-canonical pathways. This results in
increased pro-hypertrophic and pro-fibrosis gene
expression in cardiomyocytes. In view of these results,
DGCR8 decrease appears as a potential origin for the
cardiac fibrosis and hypertrophy driven by maternal
exposure to high-fat diet.
Hemin treatment rescues the levels of micro-RNAs and
genes in cardiomyocytes with low levels of Dgcr8
Since DGCR8 down-regulation leads to alterations in
cardiomyocytes, we wondered if we could rescue the
phenotype by increasing DGCR8 expression and/or
activity. Thus, we further tested the rescue of the phe-
notype through hemin treatment in cardiomyocytes
where Dgcr8 expression was decreased. Hemin, which is a
ferric form (Fe3+) of heme and which has been shown to
stimulate the microprocessor activity in vitro23–25 and
in vivo26, has been described as an efficient approach in
the reversal of fibrosis in a model of hypertension27, and
as a negative regulator of TGFβ pathway28. Therefore, we
wondered if these beneficial effects of hemin on fibrosis
and TGFβ pathway described in other models could be
Fig. 6 Effects of maternal exposure to high-fat diet on micro-RNA biogenesis. Protein levels of DGCR8, DROSHA, XPO5, DICER, and AGO2
(a) and mRNA levels of DGCR8 (b) were analyzed in the heart from male rat at post-natal day 77 under control chow diet (CTRL) or high-fat diet
(HFD). (a) A representative immunoblot image is presented for each protein. Data are expressed as the mean ± SEM; n= 13 per group. *P < 0.05 and
***P < 0.001 compared to control, ns not statistically significant
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also found in cardiomyocytes, and if those effects are
mediated by DGCR8 and micro-RNAs. To answer this
question, cardiomyocytes were treated with 1 μM hemin.
These cells exhibited increased Dgcr8 mRNA levels
compared to control cells (treated with vehicle) (Fig. 8a).
Furthermore, in cells transfected with gapmeRs, the
down-regulation in the anti-fibrotic micro-RNA miR-
101a and let-7g levels induced by Dgcr8 inhibition was
reduced when the cells were treated with hemin (gap
DGCR8 with hemin vs. gap CTRL) (Fig. 8b). Finally, the
increase in pro-fibrotic genes induced by Dgcr8 inhibition,
including Tgfβr3, Ctgf and Col3a1, was not detected
anymore when the cells were treated with hemin (gap
DGCR8 with hemin vs. gap CTRL) (Fig. 8c). Overall, these
data suggest that increasing DGCR8 expression and/or
activity in cardiomyocytes with hemin tends to rescue the
pro-fibrotic phenotype mediated by TGFβ pathway.
Discussion
Our study addresses critical health problems (obesity
and heart diseases) associated with modern lifestyle diet
(high-fat diet). Maternal obesity and high-fat diet have
been associated with increased risk for heart diseases,
notably through the induction of cardiac remodeling.
Fig. 7 DiGeorge critical region 8 (DGCR8) down-regulation in cardiomyocytes alters the levels of micro-RNA and genes involved in
transforming growth factor-beta (TGFβ)-mediated fibrosis and hypertrophy. H9C2 cells plated in 12-well plates were transfected with 20 pmol
gapmeR control (negative control, gap CTRL) or gapmeR targeting DGCR8 (gap DGCR8) for 48 h. The results are representative of two independent
experiments. In these cells, DGCR8 mRNA levels were measured by quantitative real-time PCR (RT-qPCR) (a). Let-7g, miR-21, miR-27a, miR-29c, miR-33,
miR-101a, miR-218a and miR-450a levels were measured in cells transfected with gapmeRs (b). mRNA levels of putative target genes involved in
TGFβ-mediated remodeling were analyzed (c) and (d). Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001 compared to
control, ns not statistically significant
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Indeed, maternal exposure to high-fat diet induces cardiac
hypertrophy and fibrosis that are observed early during
development (at PND1 and PND10)6,29. Our current
study showed that maternal exposure to high-fat diet
induced long-term histological and molecular changes in
the heart prior to the onset of overt obesity. Notably, the
present work highlighted the decrease in a micro-RNA
subset as a potential mechanistic basis linking maternal
nutritional imbalance early during development and
mortality related to cardiac diseases. Here, the down-
regulation of a subset of cardiac micro-RNAs induced by
maternal exposure to high-fat diet for 35 days, during
pregnancy and lactation, was detected later during life, in
adulthood. Importantly, this observation indicates that a
transient exposure to dietary distress during develop-
mental sensitive periods induces sustained down-
regulation of a micro-RNA subset. This observation is
reminiscent of the professor Barker hypothesis related to
the concept of the developmental origins of health and
disease. In this context, it is noteworthy that altered
micro-RNA patterns may be associated with disturbed
developmental processes during fetal or neonatal life.
Here, our work further highlighted micro-RNA
alterations as a possible cause for TGFβ-mediated cardiac
fibrosis and hypertrophy induced by early developmental
exposure to dietary challenge. Various intracellular sig-
naling pathways are thought to play a critical role in the
pathological remodeling of the heart and, importantly, are
activated both independently and downstream of TGF-β.
Among the targets we identified in this work, Tgfβr3 was
up-regulated. TGFβRIII is a widely expressed accessory
receptor30 for multiple classes of growth factors (includ-
ing TGF-βs, along with fibroblast growth factor (FGF),
inhibin, activin, bone morphogenetic protein (BMP)-2,
BMP-4 and BMP-7), and as such, TGFβRIII has the
potential to influence diverse cellular processes. TGFβRIII
enhances TGFβ signaling31,32 and also activates RAS-ERK
and p38 MAPK in a ligand-independent manner, both
involved in fibrosis33 and hypertrophy, in a SMAD-
independent manner. Importantly, we newly identified
alterations in DGCR8 expression as a potential cause for
long-term cardiac micro-RNA down-regulation in this
model. DGCR8 importance in micro-RNA biogenesis and
in pathophysiology has been revealed in human 22q11.2
deletion syndrome (known as DiGeorge syndrome)34 and
in animal model where the Dgcr8 gene was
Fig. 8 Hemin rescues the pro-fibrotic effect of DiGeorge critical region 8 (DGCR8) decrease in cardiomyocytes. (a) The effect of hemin on
DGCR8 mRNA levels were measured in H9C2 cells. (b) miR-101a and (c) let-7g levels and the expression of transforming growth factor-beta (TGFβ)-
mediated pro-fibrotic genes (TgfβR3, Ctgf and Col3a1) were measured in the cells transfected with the gapmeRs and treated with hemin (1 μM) or its
vehicle (water, hemin 0 μM). Data are expressed as the mean ± SEM. *P < 0.05, **P < 0.01 and ***P < 0.001
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heterozygously deleted35. The haploinsufficiency of Dgcr8
reduces the abundance of DGCR8 protein, resulting in
lower pri-micro-RNA processing efficiency and abnormal
expression of a subset of micro-RNAs36. In humans, the
DiGeorge syndrome is associated with increased risk for
congenital heart defects37. In mice, cardiomyocyte-
specific deletion of Dgcr8 induces cardiac fibrosis with
left ventricular malfunction progressing to a dilated car-
diomyopathy and premature lethality12. Our data high-
lighted a new potential pathway through which DGCR8
alterations could lead to cardiac hypertrophy and fibrosis
involving at least in part TGFβ pathway. Although mod-
ulation of TGF-β signaling with different approaches has
proven effective pre-clinically and clinically in the treat-
ment of multiple pathologies38–40, the rescue of the
phenotype remains partial. In the light of our findings,
DGCR8 appears as an attractive candidate in the reversal
of the cardiac phenotype induced by early exposure to
dietary challenge since its modulation might impact the
TGFβ signaling pathway at multiple levels. In this sense,
studies have demonstrated the possibility of regulating
DGCR8 expression and activity in several ways including
by cofactor binding, phosphorylation, acetylation and
proteolytic cleavage26,41–43. Among them, hemin, a ferric
form (Fe3+) of heme, has proven its efficiency in the up-
regulation of DGCR8 activity. Hemin is incorporated in a
DGCR8 dimer and stimulates the microprocessor activity
in vitro23–25 and in vivo26. Mechanistically, DGCR8 was
shown to depend on hemin to recognize the apical loop of
primary micro-RNA44. Furthermore, the hemin level in
human cells can impact the expression of several micro-
RNAs26 and decrease cardiac oxidative stress and fibrosis
in a rat model of systemic hypertension27. Here, we
showed that hemin can restore micro-RNA levels in
cardiomyocytes while Dgcr8 expression was decreased,
supporting the physiological function of hemin in sti-
mulating micro-RNA biogenesis and benefits for heart
functions. Similarly, through the stable binding to
DGCR8, Cobalt (III) protoporphyrin has been shown to
compensate micro-RNA processing deficiency and restore
micro-RNA levels in models where DGCR8 expression
was decreased in vivo45. Thus, it is of high interest to test
the potential of hemin treatment in the prevention and/or
reversal of cardiac alterations in animals exposed to
dietary challenge early during development.
More widely, alterations in primary micro-RNA pro-
cessing have been reported in other models of exposure to
environmental challenges such as cigarette smoke46, and
also in aging47 and in a number of human diseases
including cancer48, schizophrenia49, kidney50 and auto-
immune diseases51. To restore micro-RNA processing by
enhancing the activity of DGCR8 protein using small
molecule agents represents an interesting candidate.
Thus, the targeting of DGCR8 offers opportunities for
intervention and may emerge as an exciting and impor-
tant arena for drug development. Also, micro-RNAs are
strikingly stable and can be detected in body fluids,
including blood. This observation has raised the possibi-
lity that micro-RNAs may be probed in the circulation
and can serve as novel diagnostic markers52,53. Thus, this
is of high interest to evaluate the potential of the micro-
RNAs identified in our study as early blood-based bio-
markers of cardiac alterations induced by exposure to
dietary challenges. Our micro-RNA profile could provide
a novel strategy for diagnosis in chronic cardiac dys-




Protease inhibitor cocktail, Tween-20, Hemin, High
Pure miRNA Isolation Kit and other reagents were pur-
chased from Sigma Aldrich. Antibodies raised against
DGCR8, β-actin, anti-rabbit and anti-mouse IgG HRP-
linked antibody; BCA Protein Assay Kit; RIPA buffer;
phosphatase inhibitor cocktail; chemiluminescent western
pico plus chemiluminescent substrate, Power up Sybr-
Green Master Mix, High Capacity Reverse Transcriptions
Kit, TaqMan Advanced miRNA cDNA Synthesis Kit and
miRNA Advanced Taqman assays were purchased from
Thermo Fisher Scientific, Inc. The polyvinylidene
difluoride (PVDF) membranes were obtained from
Amersham. DICER, DROSHA, XPO5, CTGF, SPARC and
GAPDH antibodies were obtained from Santa Cruz Bio-
technology. Antibodies raised against phospho-p70 S6K
and p70 S6K were purchased from Cell Signaling Tech-
nology, Inc. GapmeRs were purchased from Qiagen.
In vivo experimental studies
The animal experiments were performed in accordance
with EU legislation (Directive 2010/63/EU) and approved
by a local animal care and use committee (Comité
Institutionnel d’Éthique Pour l’Animal de Laboratoire-
CIEPAL-Azur-Agreement number: NCE-2013-109; Pro-
tocol No. 2015-62). Pregnant Sprague Dawley rats at
gestational day 7 (GD7) (Janvier, Le Genest Saint Isle,
France) were individually housed in temperature-
controlled rooms with 12 h light/12 h dark cycles and ad
libitum access to water and feed. Upon arrival, pregnant
females were either fed with chow diet (R03, Safe, Augy,
France, n= 5) or high-fat diet (SNIFF 60%, SSNIFF, Soest,
Germany, so-called HFD, n= 5). At birth, pups were
sexed by anogenital distance and litters were culled to
5 pups per dam by removing or adding female pups as
necessary. The remaining pups were killed by CO2 inha-
lation. At PND21, all male rats were given a chow (R03).
Animals were killed by CO2 inhalation on PND77
(young adults). Each group contains 18 male rats.
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Heart sampling
The heart was quickly harvested and immediately frozen
in liquid nitrogen or fixed in paraformaldehyde and par-
affin embedded. Frozen tissues were grounded into fine
powder for further molecular analyses.
Histology, immunohistochemistry and
immunofluorescence
Heart sections (5 μm) were stained with Masson’s tri-
chrome. Five animals per group were analyzed. Image
acquisition was performed on a Nikon Eclipse Ti micro-
scope. Fibrotic area quantification was performed as
described by Chen et al.54 with ImageJ software.
Cell culture and transfection
H9C2 cardiomyocytes cell line was maintained in
medium supplemented with 10% heat-inactivated fetal
bovine serum at 37 °C in a humidified, CO2-controlled
(5%) incubator. Cells were transfected with 20 pmol gap-
meR targeting Dgcr8 (gap DGCR8) or a negative control
using Lipofectamine RNAimax Transfection reagent,
according to the manufacturer’s protocol. At 48 h fol-
lowing transfection, cells were harvested for RNAs and
protein extraction. For rescue experiments, 24 h after
transfection, cells were incubated with 1 μM hemin, or
with the vehicle (water) for 48 h.
Cell survival assay
Cells were seeded on 96-well plate and transfected with
gapmeRs. Cells were washed with phosphate buffer saline,
fixed in ice-cold methanol for 10 min and stained with
0.5% crystal violet solution at room temperature for 10
min. Optical density was measured on a plate reader
Infinite M200Pro (Nanoquant).
Protein extraction
Aliquots (~20 mg) of heart tissue powder were homo-
genized in RIPA buffer (supplemented with 1% proteases
and phosphatases inhibitor cocktail). Protein concentra-
tion was determined with the bicinchoninic acid assay. In
total, 10 to 30 μg were used for western blot analysis.
Western blotting analysis
Lysates were separated using sodium dodecyl
sulfate–polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred to PVDF membranes. The membranes
were blocked with 1% bovine serum albumin in
phosphate-buffered saline (pH 7.4) containing 0.05%
Tween-20 and were incubated with primary antibodies
and horseradish peroxidase (HRP)-conjugated secondary
anti-rabbit or -mouse antibodies. The proteins of interest
were visualized using SuperSignal West Pico PLUS Che-
miluminescent Substrate. Membranes were scanned with
a luminescent image analyzer camera G:Box (Syngene)
and quantified with Gene Tools software (Syngene).
RNA isolation
Total RNA was isolated from frozen heart powder using
1ml TRIzol reagent and 200 μl chloroform. The aqueous
phase was precipitated with 1.5 vol of ethanol 100% at 4 °C
overnight followed by 75% ethanol. Total RNAs were
further purified on a column. The RNA purity was
checked by optical density measurement at 230, 260 and
280 nm. The quantities of total RNAs and micro-RNAs
were evaluated with fluorescent-based methods on a
Qubit apparatus (Life technologies, Inc.). RNA integrity
was evaluated with a Fragment Analyzer (Agilent).
MIRNA microarray experiment
Sample quality was tested and was ranging from RQN
(RNA Quality Number) 6.7 to RQN 8.0.
To assess the effect of maternal exposure to high-fat
diet on cardiac miRNA levels, RNAs from four biological
replicates of high-fat diet vs. control diet were hybridized
on the microarrays (SurePrint Rat miRNA Microarrays,
Agilent). Each sample was prepared according to the
Agilent’s micro-RNA Microarray System protocol. The
arrays were scanned with an Agilent microarray scanner
using high dynamic range settings as specified by the
manufacturer. Agilent Feature Extraction Software Ver-
sion 10.7.3.1 was used to extract the data. Normalization
was performed on the total Gene Signal from Agilent
“GeneView” data files in R language, version 3.4, an open
source statistical scripting language (http://www.r-project.
org). Invariant-based normalization was performed as
previously described55. After normalization, micro-RNA
not detected in any sample were filtered, leaving 240
miRNAs for analysis. For statistical analyses, we per-
formed linear model using Bioconductor package Limma
with the two conditions (chow diet and high-fat diet) as
factors, extraction of contrasts of interest, moderated t-
test for comparisons were applied, adjustment of P values
by the Benjamini–Hochberg method and controlling for
false discovery rate were realized.
Pathway analysis
We performed computational target prediction analysis
coupled to pathway analysis using DIANA-miRPath (v3.0)
software. Potential target RNAs for down-regulated
micro-RNAs from each cluster were identified using the
prediction algorithm DIANA-microT-CDS (v5.0). The
potential mRNA targets for the down-regulated micro-
RNAs were then subjected to KEGG pathway analysis.
The DIANA-miRPath software calculates the significance
for all the miRNA–mRNA pairs in a pathway, and then
combines them into a merged P value for each pathway21.
Siddeek et al. Cell Death Discovery            (2019) 5:71 Page 12 of 14    71 
Official journal of the Cell Death Differentiation Association
Real-time quantitative PCR for mRNA expression
In total, 200 ng of RNAs was reverse transcribed using
High Capacity Reverse Transcription Kit according to the
manufacturer’s protocols in a SimplyAmp Thermal Cycler
(Life Technologies, Inc.). RT-qPCR was performed with
2 μl of diluted cDNA (1:20) using the I-Taq Universal
SybrGreen Master Mix and both sense and antisense
primers in a final volume of 10 μl in a Quantstudio 3
apparatus (Life Technologies, Inc.). The primers that were
used are listed in supplemental table S1. Data were nor-
malized to β-actin or to Gapdh using the Ct method.
Micro-RNA expression quantification by RT-qPCR
In total, 10 ng of RNAs was reverse transcribed with
advanced miRNA RT kit on a SimplyAmp Thermal Cycler
(Life Technologies, Inc.). RT product was diluted by 10-
fold, and 2.5 µl was used for qPCR analyses. qPCR was
performed with TaqMan Advanced Master Mix according
to the manufacturer’s protocol on a Quantstudio 3
apparatus (Life Technologies, Inc.). The relative expres-
sion levels of miRNAs were calculated using the com-
parative ΔΔCt method by normalizing to miR-16 levels.
Data analysis
The data from the different experiments were analyzed
with GraphPad Prism software version 6.05 (GraphPad
Software, Inc.). The values were expressed as mean ± SEM
to account for sample and animal variation within a
dataset. Student’s t-test was performed to determine
whether there were differences between two groups, and
analysis of variance when multiple groups were compared.
P < 0.05 was considered statistically significant.
Acknowledgements
The authors acknowledge the C3M animal room facility (Nice), Dr. Sylvain
Pradervand, the Genomics Technologies Facility (Lausanne), the mouse
pathology facility (Lausanne), and Dr. Fabienne Maurer. This work was
financially supported by the CHUV (Centre Hospitalier Universitaire Vaudoix)
and the INSERM U1065-Nice-Sophia-Antipolis University.
Authors' contributions
Conceptualization: S.B., M.B. and U.S.; methodology: S.B., C.M. and H.C.;
investigation: S.B., M.L., G.B. and M.C.; format analysis: S.B., C.M., H.C., M.B. and U.
S.; resources: M.B. and U.S.; writing: S.B., C.M., H.C., M.B. and U.S.; supervision: S.B.,
M.B. and U.S.
Conflict of interest
The authors declare that they have no conflict of interest.
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
The online version of this article (https://doi.org/10.1038/s41420-019-0153-y)
contains supplementary material, which is available to authorized users.
Received: 3 January 2019 Revised: 8 February 2019 Accepted: 13 February
2019
References
1. Jakicic, J. M., Rogers, R. J., Davis, K. K. & Collins, K. A. Role of physical activity and
exercise in treating patients with overweight and obesity. Clin. Chem. 64,
99–107 (2018).
2. Savarese, G. & Lund, L. H. Global public health burden of heart failure. Card.
Fail. Rev. 3, 7–11 (2017).
3. Reynolds, R. M. et al. Maternal obesity during pregnancy and premature
mortality from cardiovascular event in adult offspring: follow-up of 1 323 275
person years. BMJ 347, f4539 (2013).
4. Siddeek, B. et al. Transient postnatal over nutrition induces long-term altera-
tions in cardiac NLRP3-inflammasome pathway. Nutr. Metab. Cardiovasc. Dis.
28, 944–951 (2018).
5. Blackmore, H. L. et al. Maternal diet-induced obesity programs cardiovascular
dysfunction in adult male mouse offspring independent of current body
weight. Endocrinology 155, 3970–3980 (2014).
6. Maloyan, A. et al. Identification and comparative analyses of myocardial
miRNAs involved in the fetal response to maternal obesity. Physiol. Genom. 45,
889–900 (2013).
7. Velkoska, E., Cole, T. J., Dean, R. G., Burrell, L. M. & Morris, M. J. Early under-
nutrition leads to long-lasting reductions in body weight and adiposity
whereas increased intake increases cardiac fibrosis in male rats. J. Nutr. 138,
1622–1627 (2008).
8. Siddeek, B., Mauduit, C., Yzydorczyk, C., Benahmed, M. & Simeoni, U. At the
heart of programming: the role of micro-RNAs. J. Dev. Orig. Health Dis. 9,
615–631 (2018).
9. Friedman, R. C., Farh, K. K., Burge, C. B. & Bartel, D. P. Most mammalian mRNAs
are conserved targets of microRNAs. Genome Res. 19, 92–105 (2009).
10. Chen, J. F. et al. Targeted deletion of Dicer in the heart leads to dilated
cardiomyopathy and heart failure. Proc. Natl. Acad. Sci. USA 105, 2111–2116
(2008).
11. da Costa Martins, P. A. et al. Conditional dicer gene deletion in the postnatal
myocardium provokes spontaneous cardiac remodeling. Circulation 118,
1567–1576 (2008).
12. Rao, P. K. et al. Loss of cardiac microRNA-mediated regulation leads to dilated
cardiomyopathy and heart failure. Circ. Res. 105, 585–594 (2009).
13. Han, J. et al. The Drosha-DGCR8 complex in primary microRNA processing.
Genes Dev. 18, 3016–3027 (2004).
14. Yi, R., Qin, Y., Macara, I. G. & Cullen, B. R. Exportin-5 mediates the nuclear
export of pre-microRNAs and short hairpin RNAs. Genes Dev. 17, 3011–3016
(2003).
15. Wilson, R. C. et al. Dicer-TRBP complex formation ensures accurate mammalian
microRNA biogenesis. Mol. Cell 57, 397–407 (2015).
16. Maniataki, E. & Mourelatos, Z. A human, ATP-independent, RISC assembly
machine fueled by pre-miRNA. Genes Dev. 19, 2979–2990 (2005).
17. Davis, C. D. & Ross, S. A. Evidence for dietary regulation of microRNA
expression in cancer cells. Nutr. Rev. 66, 477–482 (2008).
18. Fiedler, S. D., Carletti, M. Z., Hong, X. & Christenson, L. K. Hormonal regulation of
MicroRNA expression in periovulatory mouse mural granulosa cells. Biol.
Reprod. 79, 1030–1037 (2008).
19. Kulshreshtha, R. et al. Regulation of microRNA expression: the hypoxic com-
ponent. Cell Cycle 6, 1426–1431 (2007).
20. Hudder, A. & Novak, R. F. miRNAs: effectors of environmental influences on
gene expression and disease. Toxicol. Sci. 103, 228–240 (2008).
21. Vlachos, I. S. et al. DIANA miRPath v.2.0: investigating the combinatorial effect
of microRNAs in pathways. Nucleic Acids Res. 40, W498–W504 (2012).
22. Dobaczewski, M., Chen, W. & Frangogiannis, N. G. Transforming growth factor
(TGF)-beta signaling in cardiac remodeling. J. Mol. Cell. Cardiol. 51, 600–606
(2011).
23. Faller, M., Matsunaga, M., Yin, S., Loo, J. A. & Guo, F. Heme is involved in
microRNA processing. Nat. Struct. Mol. Biol. 14, 23–29 (2007).
24. Barr, I. et al. DiGeorge critical region 8 (DGCR8) is a double-cysteine-ligated
heme protein. J. Biol. Chem. 286, 16716–16725 (2011).
25. Barr, I. et al. Ferric, not ferrous, heme activates RNA-binding protein DGCR8 for
primary microRNA processing. Proc. Natl. Acad. Sci. USA 109, 1919–1924 (2012).
26. Weitz, S. H., Gong, M., Barr, I., Weiss, S. & Guo, F. Processing of microRNA
primary transcripts requires heme in mammalian cells. Proc. Natl. Acad. Sci. USA
111, 1861–1866 (2014).
Siddeek et al. Cell Death Discovery            (2019) 5:71 Page 13 of 14    71 
Official journal of the Cell Death Differentiation Association
27. Worou, M. E. et al. Hemin decreases cardiac oxidative stress and fibrosis in a rat
model of systemic hypertension via PI3K/Akt signalling. Cardiovasc. Res. 91,
320–329 (2011).
28. Zhu, X. et al. HMOX-1 inhibits TGF-beta-induced epithelial-mesenchymal
transition in the MCF-7 breast cancer cell line. Int. J. Mol. Med. 40, 411–417
(2017).
29. De Jong, K. A. et al. Maternal high fat diet induces early cardiac hypertrophy
and alters cardiac metabolism in Sprague Dawley rat offspring. Nutr. Metab.
Cardiovasc. Dis. 28, 600–609 (2018).
30. Bilandzic, M. & Stenvers, K. L. Betaglycan: a multifunctional accessory. Mol. Cell.
Endocrinol. 339, 180–189 (2011).
31. Lopez-Casillas, F., Wrana, J. L. & Massague, J. Betaglycan presents ligand to the
TGF beta signaling receptor. Cell 73, 1435–1444 (1993).
32. Groeneveld, M. E. et al. Betaglycan (TGFBR3) up-regulation correlates with
increased TGF-beta signaling in Marfan patient fibroblasts in vitro. Cardiovasc.
Pathol. 32, 44–49 (2018).
33. Liao, P. et al. The in vivo role of p38 MAP kinases in cardiac remodeling
and restrictive cardiomyopathy. Proc. Natl. Acad. Sci. USA 98, 12283–12288
(2001).
34. Karayiorgou, M., Simon, T. J. & Gogos, J. A. 22q11.2 microdeletions: linking DNA
structural variation to brain dysfunction and schizophrenia. Nat. Rev. Neurosci.
11, 402–416 (2010).
35. Shiohama, A., Sasaki, T., Noda, S., Minoshima, S. & Shimizu, N. Molecular cloning
and expression analysis of a novel gene DGCR8 located in the DiGeorge
syndrome chromosomal region. Biochem. Biophys. Res. Commun. 304,
184–190 (2003).
36. Stark, K. L. et al. Altered brain microRNA biogenesis contributes to phenotypic
deficits in a 22q11-deletion mouse model. Nat. Genet. 40, 751–760 (2008).
37. Marino, B., Digilio, M. C., Toscano, A., Giannotti, A. & Dallapiccola, B. Congenital
heart defects in patients with DiGeorge/velocardiofacial syndrome and
del22q11. Genet. Couns. 10, 25–33 (1999).
38. Noble, P. W. et al. Pirfenidone in patients with idiopathic pulmonary fibrosis
(CAPACITY): two randomised trials. Lancet 377, 1760–1769 (2011).
39. Gallo, E. M. et al. Angiotensin II-dependent TGF-beta signaling contributes to
Loeys-Dietz syndrome vascular pathogenesis. J. Clin. Invest. 124, 448–460
(2014).
40. Habashi, J. P. et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a
mouse model of Marfan syndrome. Science 312, 117–121 (2006).
41. Gong, M. et al. Caspases cleave and inhibit the microRNA processing protein
DiGeorge Critical Region 8. Protein Sci. 21, 797–808 (2012).
42. Herbert, K. M., Pimienta, G., DeGregorio, S. J., Alexandrov, A. & Steitz, J. A.
Phosphorylation of DGCR8 increases its intracellular stability and induces a
progrowth miRNA profile. Cell Rep. 5, 1070–1081 (2013).
43. Wada, T., Kikuchi, J. & Furukawa, Y. Histone deacetylase 1 enhances microRNA
processing via deacetylation of DGCR8. EMBO Rep. 13, 142–149 (2012).
44. Nguyen, T. A., Park, J., Dang, T. L., Choi, Y. G. & Kim, V. N. Microprocessor
depends on hemin to recognize the apical loop of primary microRNA. Nucleic
Acids Res. 46, 5726–5736 (2018).
45. Barr, I. et al. Cobalt(III) protoporphyrin activates the DGCR8 protein and can
compensate microRNA processing deficiency. Chem. Biol. 22, 793–802 (2015).
46. Izzotti, A. et al. Downregulation of microRNA expression in the lungs of rats
exposed to cigarette smoke. FASEB J. 23, 806–812 (2009).
47. Abdelmohsen, K., Srikantan, S., Kang, M. J. & Gorospe, M. Regulation of
senescence by microRNA biogenesis factors. Ageing Res. Rev. 11, 491–500
(2012).
48. Williams, M., Cheng, Y. Y., Blenkiron, C. & Reid, G. Exploring mechanisms of
microRNA downregulation in cancer. Microrna 6, 2–16 (2017).
49. Beveridge, N. J., Gardiner, E., Carroll, A. P., Tooney, P. A. & Cairns, M. J. Schi-
zophrenia is associated with an increase in cortical microRNA biogenesis. Mol.
Psychiatry 15, 1176–1189 (2010).
50. Bartram, M. P. et al. Loss of Dgcr8-mediated microRNA expression in the
kidney results in hydronephrosis and renal malformation. BMC Nephrol. 16, 55
(2015).
51. Jeker, L. T., Zhou, X., Blelloch, R. & Bluestone, J. A. DGCR8-mediated production
of canonical microRNAs is critical for regulatory T cell function and stability.
PLoS ONE 8, e66282 (2013).
52. Siddeek, B. et al. Developmental epigenetic programming of adult germ cell
death disease: polycomb protein EZH2-miR-101 pathway. Epigenomics 8,
1459–1479 (2016).
53. Siddeek, B. et al. MicroRNAs as potential biomarkers in diseases and toxicology.
Mutat. Res Genet Toxicol. Environ. Mutagen 764-765, 46–57 (2014).
54. Chen, Y., Yu, Q. & Xu, C.-B. A convenient method for quantifying collagen
fibers in atherosclerotic lesions by ImageJ software. Int. J. Clin. Exp. Med. 10,
14904–14910 (2017).
55. Pradervand, S. et al. Impact of normalization on miRNA microarray expression
profiling. RNA 15, 493–501 (2009).
Siddeek et al. Cell Death Discovery            (2019) 5:71 Page 14 of 14    71 
Official journal of the Cell Death Differentiation Association
